Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Current Assignee (The listed assignees may be inaccurate. Google has not performed a legal analysis and makes no representation or warranty as to the accuracy of the list.)
Sirna Therapeutics Inc
Original Assignee
Sirna Therapeutics Inc
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Priority claimed from US10/444,853external-prioritypatent/US8202979B2/en
Priority claimed from US10/693,059external-prioritypatent/US20080039414A1/en
Priority claimed from US10/720,448external-prioritypatent/US8273866B2/en
Priority claimed from US10/727,780external-prioritypatent/US20050233329A1/en
Priority claimed from US10/757,803external-prioritypatent/US20050020525A1/en
Priority claimed from US10/780,447external-prioritypatent/US7491805B2/en
Priority claimed from US10/826,966external-prioritypatent/US20050032733A1/en
Application filed by Sirna Therapeutics IncfiledCriticalSirna Therapeutics Inc
Priority claimed from PCT/US2004/016390external-prioritypatent/WO2005019453A2/en
Publication of DE602004022535D1publicationCriticalpatent/DE602004022535D1/de
DURCH RNA-INTERFERENZ VERMITTELTE HEMMUNG DER EXPRESSION DES GENS DER PROTEIN-TYROSINPHOSPHATASE-1B (PTP-1B) UNTER VERWENDUNG VON SiNA (SHORT INTERFERING NUCLEIC ACID)
Rna-interferenz-vermittelte hemmung der expression des gens für proteinkinase c-alpha (pkc-alpha) unter verwendung von sina (short interfering nucleic acid)